Stocks and Investing Stocks and Investing
Tue, September 1, 2020
Mon, August 31, 2020

Matt Miksic Maintained (ABT) at Buy with Increased Target to $136 on, Aug 31st, 2020


Published on 2024-10-27 12:50:39 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $109 to $136 on, Aug 31st, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 6 analyists that currently disagree with Matt


  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
Contributing Sources